Delcath Systems, Inc. (DCTH)
15.67
+0.31
(+2.02%)
USD |
NASDAQ |
Oct 12, 16:00
15.68
+0.01
(+0.06%)
After-Hours: 20:00
Delcath Systems Enterprise Value : 449.31M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 449.31M |
| October 09, 2026 | 438.57M |
| October 08, 2026 | 427.49M |
| October 07, 2026 | 439.27M |
| October 06, 2026 | 440.31M |
| October 05, 2026 | 456.24M |
| October 02, 2026 | 430.61M |
| October 01, 2026 | 440.31M |
| September 30, 2026 | 459.70M |
| September 29, 2026 | 455.55M |
| September 28, 2026 | 454.16M |
| September 25, 2026 | 446.89M |
| September 24, 2026 | 463.51M |
| September 23, 2026 | 459.36M |
| September 22, 2026 | 474.60M |
| September 21, 2026 | 464.55M |
| September 18, 2026 | 464.55M |
| September 17, 2026 | 469.40M |
| September 16, 2026 | 468.36M |
| September 15, 2026 | 466.63M |
| September 14, 2026 | 475.98M |
| September 11, 2026 | 457.62M |
| September 10, 2026 | 453.81M |
| September 09, 2026 | 460.05M |
| September 08, 2026 | 463.51M |
| Date | Value |
|---|---|
| September 04, 2026 | 477.37M |
| September 03, 2026 | 477.37M |
| September 02, 2026 | 480.83M |
| September 01, 2026 | 474.60M |
| August 31, 2026 | 476.67M |
| August 28, 2026 | 472.52M |
| August 27, 2026 | 474.25M |
| August 26, 2026 | 474.60M |
| August 25, 2026 | 492.61M |
| August 24, 2026 | 486.72M |
| August 21, 2026 | 500.23M |
| August 20, 2026 | 486.72M |
| August 19, 2026 | 500.57M |
| August 18, 2026 | 490.53M |
| August 17, 2026 | 497.11M |
| August 14, 2026 | 486.03M |
| August 13, 2026 | 507.85M |
| August 12, 2026 | 499.19M |
| August 11, 2026 | 503.00M |
| August 10, 2026 | 483.95M |
| August 07, 2026 | 429.92M |
| August 06, 2026 | 442.38M |
| August 05, 2026 | 344.02M |
| August 04, 2026 | 361.68M |
| August 03, 2026 | 358.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 203.84B |
| AngioDynamics, Inc. | 460.40M |
| Alphatec Holdings, Inc. | 2.227B |
| AtriCure, Inc. | 2.820B |
| Baxter International, Inc. | 19.49B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.668M |
| Revenue (Quarterly) | 29.13M |
| Total Expenses (Quarterly) | 26.46M |
| EPS Diluted (Quarterly) | 0.0671 |
| Gross Profit Margin (Quarterly) | 89.75% |
| Profit Margin (Quarterly) | 9.16% |
| Earnings Yield | 0.04% |
| Normalized Earnings Yield | 0.0389 |